112 related articles for article (PubMed ID: 29209796)
1. [Spindle-cell osteosclerotic bone lesion with MDM2 amplification].
Mogler C; Boxberg M; Knebel C; Weichert W; Wörtler K; Specht K
Pathologe; 2018 Mar; 39(2):186-190. PubMed ID: 29209796
[TBL] [Abstract][Full Text] [Related]
2. DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours.
Courjal F; Cuny M; Rodriguez C; Louason G; Speiser P; Katsaros D; Tanner MM; Zeillinger R; Theillet C
Br J Cancer; 1996 Dec; 74(12):1984-9. PubMed ID: 8980401
[TBL] [Abstract][Full Text] [Related]
3. The MDM2 SNP309 G allele is not preferentially amplified in bone and soft tissue tumors.
Mertens F; Brosjö O; von Steyern FV; Nord KH; Mandahl N
Cancer Genet; 2012 Sep; 205(9):470-3. PubMed ID: 22939400
[TBL] [Abstract][Full Text] [Related]
4. MDM2 gene amplification in bone and soft-tissue tumors: association with tumor progression in differentiated adipose-tissue tumors.
Nakayama T; Toguchida J; Wadayama B; Kanoe H; Kotoura Y; Sasaki MS
Int J Cancer; 1995 Oct; 64(5):342-6. PubMed ID: 7591308
[TBL] [Abstract][Full Text] [Related]
5. MDM2 and CDK4 gene amplification in Ewing's sarcoma.
Ladanyi M; Lewis R; Jhanwar SC; Gerald W; Huvos AG; Healey JH
J Pathol; 1995 Feb; 175(2):211-7. PubMed ID: 7738717
[TBL] [Abstract][Full Text] [Related]
6. Amplification of FRS2 in atypical lipomatous tumour/well-differentiated liposarcoma and de-differentiated liposarcoma: a clinicopathological and genetic study of 146 cases.
Jing W; Lan T; Chen H; Zhang Z; Chen M; Peng R; He X; Zhang H
Histopathology; 2018 Jun; 72(7):1145-1155. PubMed ID: 29368794
[TBL] [Abstract][Full Text] [Related]
7. MDM2 amplification is an independent prognostic feature of node-negative, estrogen receptor-positive early-stage breast cancer.
Choschzick M; Heilenkötter U; Lebeau A; Jaenicke F; Terracciano L; Bokemeyer C; Sauter G; Simon R
Cancer Biomark; 2010-2011; 8(2):53-60. PubMed ID: 21896991
[TBL] [Abstract][Full Text] [Related]
8. Expression of alternatively-spliced MDM2 transcripts in giant cell tumours of bone.
Evdokiou A; Atkins GJ; Bouralexis S; Hay S; Raggatt LJ; Cowled PA; Graves SE; Clayer M; Findlay DM
Int J Oncol; 2001 Sep; 19(3):625-32. PubMed ID: 11494046
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma.
Mejia-Guerrero S; Quejada M; Gokgoz N; Gill M; Parkes RK; Wunder JS; Andrulis IL
Genes Chromosomes Cancer; 2010 Jun; 49(6):518-25. PubMed ID: 20196171
[TBL] [Abstract][Full Text] [Related]
10. MDM2 and CDK4 amplifications are rare events in salivary duct carcinomas.
Grünewald I; Trautmann M; Busch A; Bauer L; Huss S; Schweinshaupt P; Vollbrecht C; Odenthal M; Quaas A; Büttner R; Meyer MF; Beutner D; Hüttenbrink KB; Wardelmann E; Stenner M; Hartmann W
Oncotarget; 2016 Nov; 7(46):75261-75272. PubMed ID: 27662657
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive mapping of p53 pathway alterations reveals an apparent role for both SNP309 and MDM2 amplification in sarcomagenesis.
Ito M; Barys L; O'Reilly T; Young S; Gorbatcheva B; Monahan J; Zumstein-Mecker S; Choong PF; Dickinson I; Crowe P; Hemmings C; Desai J; Thomas DM; Lisztwan J
Clin Cancer Res; 2011 Feb; 17(3):416-26. PubMed ID: 21159888
[TBL] [Abstract][Full Text] [Related]
12. Genomic aberrations of MDM2, MDM4, FGFR1 and FGFR3 are associated with poor outcome in patients with salivary gland cancer.
Ach T; Schwarz-Furlan S; Ach S; Agaimy A; Gerken M; Rohrmeier C; Zenk J; Iro H; Brockhoff G; Ettl T
J Oral Pathol Med; 2016 Aug; 45(7):500-9. PubMed ID: 26661925
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of p53, MDM2, and H-ras genes in osteosarcoma and malignant fibrous histiocytoma of bone in patients older than 40 years.
Kawaguchi K; Oda Y; Sakamoto A; Saito T; Tamiya S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2002 Aug; 15(8):878-88. PubMed ID: 12181274
[TBL] [Abstract][Full Text] [Related]
14. Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation.
Kanoe H; Nakayama T; Murakami H; Hosaka T; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Sasaki MS; Toguchida J
Anticancer Res; 1998; 18(4A):2317-21. PubMed ID: 9703873
[TBL] [Abstract][Full Text] [Related]
15. Primary extraskeletal osteosarcoma: a clinicopathological study of 18 cases focusing on MDM2 amplification status.
Yamashita K; Kohashi K; Yamada Y; Nishida Y; Urakawa H; Oda Y; Toyokuni S
Hum Pathol; 2017 May; 63():63-69. PubMed ID: 28235629
[TBL] [Abstract][Full Text] [Related]
16. The value of MDM2 and CDK4 amplification levels using real-time polymerase chain reaction for the differential diagnosis of liposarcomas and their histologic mimickers.
Shimada S; Ishizawa T; Ishizawa K; Matsumura T; Hasegawa T; Hirose T
Hum Pathol; 2006 Sep; 37(9):1123-9. PubMed ID: 16938516
[TBL] [Abstract][Full Text] [Related]
17. MDM2 gene amplification in esophageal carcinoma.
Michalk M; Meinrath J; Künstlinger H; Koitzsch U; Drebber U; Merkelbach-Bruse S; Bollschweiler E; Kloth M; Hartmann W; Hölscher A; Quaas A; Grimminger PP; Odenthal M
Oncol Rep; 2016 Apr; 35(4):2223-7. PubMed ID: 26796597
[TBL] [Abstract][Full Text] [Related]
18. MDM2 gene amplification is correlated to tumor progression but not to the presence of SNP309 or TP53 mutational status in primary colorectal cancers.
Forslund A; Zeng Z; Qin LX; Rosenberg S; Ndubuisi M; Pincas H; Gerald W; Notterman DA; Barany F; Paty PB
Mol Cancer Res; 2008 Feb; 6(2):205-11. PubMed ID: 18314481
[TBL] [Abstract][Full Text] [Related]
19. A new subtype of high-grade mandibular osteosarcoma with RASAL1/MDM2 amplification.
Guérin M; Thariat J; Ouali M; Bouvier C; Decouvelaere AV; Cassagnau E; Aubert S; Lepreux S; Coindre JM; Valmary-Degano S; Larousserie F; Meilleroux J; Projetti F; Stock N; Galant C; Marie B; Peyrottes I; de Pinieux G; Gomez-Brouchet A
Hum Pathol; 2016 Apr; 50():70-8. PubMed ID: 26997440
[TBL] [Abstract][Full Text] [Related]
20. MDM2 amplification in a primary alveolar rhabdomyosarcoma displaying a t(2;13)(q35;q14).
Meddeb M; Valent A; Danglot G; Nguyen VC; Duverger A; Fouquet F; Terrier-Lacombe MJ; Oberlin O; Bernheim A
Cytogenet Cell Genet; 1996; 73(4):325-30. PubMed ID: 8751388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
